This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xiao, F. Articles by Klug, J. Search for Related Content PubMed PubMed Citation Articles by Xiao, F. Articles by Klug, J.

Secretoglobin 2A1 Is under Selective Androgen Control Mediated by a Peculiar Binding Site for Sp Family Transcription Factors

Institut für Anatomie und Zellbiologie (F.X., J.K.), Justus-Liebig-Universität Giessen, D-35385 Giessen, Germany; Institut für Molekularbiologie und Tumorforschung (A.M.), Philipps-Universität Marburg, D-35033 Marburg, Germany; and Institut für Humangenetik und Anthropologie (M.P., A.B.), Klinikum der Friedrich-Schiller-Universität Jena, 07740 Jena, Germany

Address all correspondence and requests for reprints to: Dr. Jörg Klug, Justus-Liebig-Universität Giessen, Institut für Anatomie und Zellbiologie, Aulweg 123, D-35385 Giessen, Germany. E-mail: joerg.klug{at}anatomie.med.uni-giessen.de.

Human secretoglobin (SCGB) 2A1 (or lipophilin C, lacryglobin, mammaglobin B) is a small protein of unknown function that forms heterodimers with secretoglobin 1D1 (lipophilin A) in tears and is expressed in the prostate. Here we show that SCGB 2A1 is under androgen control in the androgen-responsive prostatic cell line LNCaP and can be induced more than 20-fold by dihydrotestosterone. Only 6 h after androgen treatment, a strong DNase I-hypersensitive site is induced in the proximal promoter within chromatin. Within the boundaries of this DNase I-hypersensitive site a minimal 32-bp peculiar dimeric inverted repeat variant GC box (dim-IR-GA box) was found to confer androgen but not glucocorticoid responsiveness in gene transfer experiments. Mutations of both GA boxes that abolish binding of Sp1 and Sp3 also abrogate the androgen response. In an EMSA the DNA binding domain of the androgen receptor (AR) was not able to bind directly to the dim-IR-GA box. However, AR is functionally required for the hormone response because induction can be inhibited with the nonsteroidal antagonist bicalutamide. Chromatin immunoprecipitation experiments demonstrated that AR is recruited to the proximal promoter 10 min after androgen treatment. Therefore we propose that SCGB 2A1 represents a new class of androgen target genes that are purely under indirect AR control mediated by DNA-bound Sp factors.

NURSA Molecule Pages Link:

Nuclear Receptors:   ERα  |  ERβ  |  AR

Coregulators:   GRIP1

Ligands:   Dexamethasone  |  17β-Estradiol  |  Dihydrotestosterone  |  Diethylstilbestrol  |  4-Hydroxytamoxifen  |  Raloxifene  |  Bicalutamide  |  R1881

This article has been cited by other articles:

				M. H. Hong, H. Sun, C. H. Jin, M. Chapman, J. Hu, W. Chang, K. Burnett, J. Rosen, A. Negro-Vilar, and J. N. Miner Cell-Specific Activation of the Human Skeletal {alpha}-Actin by Androgens Endocrinology, March 1, 2008; 149(3): 1103 - 1112. [Abstract] [Full Text] [PDF]

				P. J I Ellis, R. A Furlong, S. J Conner, J. Kirkman-Brown, M. Afnan, C. Barratt, D. K Griffin, and N. A Affara Coordinated transcriptional regulation patterns associated with infertility phenotypes in men J. Med. Genet., August 1, 2007; 44(8): 498 - 508. [Abstract] [Full Text] [PDF]

				U. Moehren, M. Papaioannou, C. A. Reeb, W. Hong, and A. Baniahmad Alien Interacts with the Human Androgen Receptor and Inhibits Prostate Cancer Cell Growth Mol. Endocrinol., May 1, 2007; 21(5): 1039 - 1048. [Abstract] [Full Text] [PDF]

				M. Lacroix Significance, detection and markers of disseminated breast cancer cells Endocr. Relat. Cancer, December 1, 2006; 13(4): 1033 - 1067. [Abstract] [Full Text] [PDF]